0001179110-19-004715.txt : 20190403
0001179110-19-004715.hdr.sgml : 20190403
20190403181533
ACCESSION NUMBER: 0001179110-19-004715
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190401
FILED AS OF DATE: 20190403
DATE AS OF CHANGE: 20190403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scoggins Christopher J
CENTRAL INDEX KEY: 0001772286
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 19730493
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
3
1
edgar.xml
FORM 3 -
X0206
3
2019-04-01
0
0000001800
ABBOTT LABORATORIES
ABT
0001772286
Scoggins Christopher J
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
0
1
0
0
Senior Vice President
Common shares without par value
25300
D
Option (right to buy)
48.04
2016-06-15
2025-06-14
Common shares
47226
D
Option (right to buy)
38.40
2017-02-19
2026-02-18
Common shares
15000
D
Option (right to buy)
44.40
2018-02-17
2027-02-16
Common shares
22196
D
Option (right to buy)
59.94
2019-02-16
2028-02-15
Common shares
64449
D
Option (right to buy)
75.90
2020-02-22
2029-02-21
Common shares
51557
D
Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable in annual increments of 15,742 on June 15, 2016, 15,742 on June 15, 2017, and 15,742 on June 15, 2018.
Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable in annual increments and became fully exercisable on February 19, 2019.
Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of which 7,399 and 7,398 became exercisable on February 17, 2018 and February 17, 2019, respectively, and 7,399 becomes exercisable on February 17, 2020.
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of which 21,483 became exercisable on February 16, 2019 and 21,483 and 21,483 becomes exercisable on February 16, 2020 and February 16, 2021, respectively.
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 17,185 on February 22, 2020, 17,186 on February 22, 2021, and 17,186 on February 22, 2022.
Jessica H. Paik, by power of attorney for Christopher J. Scoggins
2019-04-03
EX-24
2
ex24scoggins.txt
Exhibit 24.1
POWER OF ATTORNEY
The undersigned constitutes and appoints HUBERT L. ALLEN, JESSICA
H. PAIK, and AARON N. RICE, and each of them individually, as the
undersigned's true and lawful attorney-in-fact and agent, with
full power of substitution and re-substitution, for the
undersigned and in the undersigned's name, place and stead,
to prepare and sign any and all Securities and Exchange Commission
("SEC") Notices of Proposed Sales of Securities pursuant to Rule 144
under the Securities Act of 1933 on Form 144, all SEC statements
on Forms 3, 4 and 5 as required under Section 16(a) of the Securities
Exchange Act of 1934, including a Form ID and any other documents
necessary to obtain codes and passwords necessary to make electronic
filings, and any amendments to such forms, and to file the same with
all exhibits thereto, and other documents in connection therewith,
with the SEC, granting unto said attorney-in-fact and agent full
power and authority to do and perform each act and thing requisite,
necessary or desirable to be done under said Rule 144 and Section
16(a), as fully for all intents and purposes as the undersigned
might or could do in person, hereby ratifying and confirming all
that said attorney-in-fact and agent may lawfully do or cause to be
done by virtue hereof.
A copy of this power of attorney shall be filed with the SEC. The
authorization set forth above shall continue in full force and effect
until the undersigned is no longer required to file Forms 144, 3, 4, or
5 or if earlier, until the undersigned revokes such authorization by
written instructions to the attorney-in-fact.
Date: March 26, 2019
/s/ Christopher J. Scoggins
Signature of Reporting Person
Christsopher J. Scoggins
Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064